Sponsor

Leiden University Medical Center

Clinical research sponsor

How to interpret these research links

Connected source records

The exact organization name Leiden University Medical Center appears in 91 distinct published trial records. The links retain registry-reported sponsor and collaborator roles; differently spelled legal entities are not automatically merged. Recruiting status describes the current published registry snapshot, not an independently verified availability guarantee.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Published trials91
Recruiting shown14
Roles2
SourceClinicalTrials.gov
Advertisement

Clinical trials

60 shown
Making Diabetes Care Fit for Young Adults Living With Type 1 Diabetes: Observations, Reflections and Expert OpinionsNCT07498738 · lead sponsor · 2026-03-13
RECRUITING
The 4D PICTURE Project: Evaluating Metro Mapping As a Method to Support Shared Decision Making in OncologyNCT06685562 · lead sponsor · 2023-12-20
RECRUITING
Non-Invasive Portal and Hepatic Vein Pressure EstimationNCT06210178 · lead sponsor · 2023-12-01
RECRUITING
Adult Congenital Heart Disease International EValuation of the Effectiveness of SGLT2i RegistryNCT06932081 · lead sponsor · 2023-01-01
RECRUITING
Phase II Randomised Controlled Trial of Patient-specific Adaptive vs. Continuous Abiraterone or eNZalutamide in mCRPCNCT05393791 · lead sponsor · 2022-11-10
RECRUITING
Real-World Data on the Effects of Cardiac Resynchronization Therapy in Adult Patients With Congenital Heart DiseaseNCT06969924 · lead sponsor · 2014-01-01
RECRUITING
Semaglutide in Patients Undergoing Transcatether Aortic Valve ReplacementNCT07090343 · lead sponsor · 2026-04-01
NOT_YET_RECRUITING
Optic Nerve Sheath Diameter in Hypertensive EmergencyNCT06286696 · lead sponsor · 2024-11-01
NOT_YET_RECRUITING
Bladder Complaints in Parkinson's Disease Effectiveness of Pelvic Floor Muscle Exercises and Electrical StimulationNCT05814614 · lead sponsor · 2023-09-25
UNKNOWN
DIAbetes Maximal ACCelerationNCT05646147 · lead sponsor · 2023-07-01
UNKNOWN
Fasting Mimicking Diet Program to ImpRovE ChemoTherapy in Hormone Receptor Postive (HR+), HER2- Breast CancerNCT05503108 · lead sponsor · 2023-03-17
SUSPENDED
Arginine-stimulated Indication of Early Outcome After Islet TransplantationNCT05540197 · lead sponsor · 2023-02-23
UNKNOWN
Digitally Supported Self-management Program for Patients With Asthma in Secondary Care: a Pilot StudyNCT05643183 · lead sponsor · 2022-11-21
COMPLETED
Januse Kinase Inhibition With Filgotinib to Silence Autoreactive B Cells in Rheumatoid ArthritisNCT05502731 · lead sponsor · 2022-10-01
UNKNOWN
Response and Toxicity Prediction by Microbiome Analysis After (Concurrent) ChemoradiotherapyNCT04711330 · lead sponsor · 2022-09-01
ACTIVE_NOT_RECRUITING
PSMA Expression and PSMA PET Imaging in Soft Tissue Sarcomas and Urothelial Cell CarcinomasNCT05522257 · lead sponsor · 2022-08-01
COMPLETED
The Stroke Box: a Patient-centered eHealth Approach for Improving Post-stroke Care.NCT05388578 · lead sponsor · 2022-07-07
UNKNOWN
Clinical Outcome After Total Pancreatectomy With Islet AutotransplantationNCT05287737 · lead sponsor · 2022-06-21
ENROLLING_BY_INVITATION
Carotid Body Function in Type 2 Diabetes MellitusNCT05237076 · lead sponsor · 2021-12-01
COMPLETED
Prevention of Low Blood Pressure After Cardiac Surgery in Heart Failure Patients With a Filter Called CytoSorb.NCT04812717 · lead sponsor · 2021-10-27
UNKNOWN
Electrophysiology of the Human Pituitary GlandNCT05338125 · lead sponsor · 2020-12-10
TERMINATED
SGM-101 in Colorectal Lung MetastasesNCT04737213 · lead sponsor · 2020-11-01
UNKNOWN
COVID-19 Glycemic Control StudyNCT05977205 · lead sponsor · 2020-05-02
COMPLETED
Safety and Efficiency of the YEARS Algorithm Versus Computed Tomography Pulmonary Angiography Alone for Suspected Pulmonary Embolism in Patients With MalignancyNCT04657120 · lead sponsor · 2019-06-01
COMPLETED
Circadian Rhythmicity in Cold-induced ThermogenesisNCT04406922 · lead sponsor · 2019-04-23
COMPLETED
Bayesian Hemodynamics Model for Personalized Monitoring of Congestive Heart Failure PatientsNCT03575533 · lead sponsor · 2019-01-01
UNKNOWN
"POWER2DM Evaluation Campaign"NCT03588104 · lead sponsor · 2018-12-03
COMPLETED
Clinical Feasibility and Efficacy of Intermittent Use of a Fasting Mimicking Diet in the Treatment of Type 2 DiabetesNCT03811587 · lead sponsor · 2018-11-05
COMPLETED
Abatacept to Silence Anti-citrullinated Protein Antibody-expressing B Cells in Rheumatoid Arthritis (ASCARA)NCT03492658 · lead sponsor · 2018-05-17
COMPLETED
Dietary Interventions on Glycocalyx Dimensions in South Asian Patients With Diabetic Nephropathy.NCT03889236 · lead sponsor · 2018-05-03
COMPLETED
Shorter Scalp Cooling Time in PaclitaxelNCT03266185 · lead sponsor · 2017-12-20
COMPLETED
Leiden University Medical Center Mini Donor BankNCT02810613 · lead sponsor · 2016-05-31
WITHDRAWN
Reducing Dexamethasone Around Docetaxel InfusionNCT02776436 · lead sponsor · 2016-01-01
COMPLETED
Effect of Deep Neuromuscular Block on Surgical Conditions in Morbidly Obese PatientsNCT02553629 · lead sponsor · 2015-09-01
COMPLETED
Effect of Liraglutide on Cardiovascular Endpoints in Diabetes Mellitus Type 2 Patients of South Asian DescentNCT02660047 · lead sponsor · 2015-08-01
COMPLETED
DIetary REstriction as an Adjunct to Neoadjuvant ChemoTherapy for HER2 Negative Breast CancerNCT02126449 · lead sponsor · 2014-02-01
COMPLETED
Effect of Neuromuscular Block and Arterial PCO2 on Surgical Rating Scale (SRS), Following Reversal With SugammadexNCT01968447 · lead sponsor · 2014-02-01
COMPLETED
Effect of Liraglutide on Cardiovascular Endpoints in Diabetes Mellitus Type 2 PatientsNCT01761318 · lead sponsor · 2013-11-01
COMPLETED
Levosimendan Pharmacokinetics in ChildrenNCT01704131 · lead sponsor · 2012-11-01
UNKNOWN
Aspirin in Reduction of Tension II StudyNCT01379079 · lead sponsor · 2011-04-01
COMPLETED
Effects of Short-term Fasting on Tolerance to ChemotherapyNCT01304251 · lead sponsor · 2011-03-01
COMPLETED
Biomarkers in Chronic Obstructive Pulmonary Disease (COPD)NCT01145300 · lead sponsor · 2010-06-01
COMPLETED
Vaccination Response in ImmunoCompromised Host. Immune Response After Vaccination Against Pandemic A/H1N1 InfluenzaNCT01066169 · lead sponsor · 2009-11-01
COMPLETED
Hypothalamic Function Before and After Bariatric SurgeryNCT01167959 · lead sponsor · 2009-06-01
COMPLETED
The Netherlands Epidemiology of Obesity StudyNCT03410316 · lead sponsor · 2008-08-04
ACTIVE_NOT_RECRUITING
Early Migration in a High Congruent Rotating Platform Total Knee Prosthesis DesignNCT01102829 · lead sponsor · 2007-09-01
COMPLETED
Towards Restoring the Physiological Inhibition of Airway Narrowing in AsthmaNCT00279136 · lead sponsor · 2004-09-01
UNKNOWN
Modification Of Disease Outcome In COPDNCT00158847 · lead sponsor · 2000-04-01
TERMINATED
Rheumatoid Arthritis Patients in TrainingNCT00434200 · lead sponsor · 1998-01-01
UNKNOWN
Combination Chemotherapy Compared With Mitoxantrone in Treating Older Patients With Advanced Breast CancerNCT00002498 · lead sponsor · 1992-07-01
UNKNOWN
Asthma Management Project University LeidenNCT00279188 · lead sponsor · 1992-05-01
COMPLETED
MethMax Trial: MAXimising the METHotrexate Therapy Potential in Patients With Active Rheumatoid ArthritisNCT06649136 · collaborator · 2024-08-12
RECRUITING
Global Research Initiative for Patients Screening on MASHNCT05651724 · collaborator · 2023-06-30
RECRUITING
Comparison of Standard Dose Alectinib to Alectinib in Adjusted Dose Based on Alectinib BloodlevelsNCT05525338 · collaborator · 2022-03-23
RECRUITING
Restoring 24-hour Substrate Rhythmicity to Improve Glycemic Control by Timing of Lifestyle FactorsNCT05123963 · collaborator · 2021-09-15
RECRUITING
Better After CHoosing. Randomly Allocated or Patient Preference Based Treatment With Filgotinib or TNFi in RA (BACH)NCT04985435 · collaborator · 2021-05-12
RECRUITING
Prevention of Post-TIPS Hepatic Encephalopathy by Administration of Rifaximin and LactuloseNCT04073290 · collaborator · 2020-01-21
RECRUITING
FUnctional Selection of Advanced Breast Cancer Patients for Talazoparib Treatment Using the REpair Capacity (RECAP) TestNCT06193525 · collaborator · 2019-09-16
RECRUITING
Netherlands Cohort Study on Acute HIV InfectionNCT05728996 · collaborator · 2015-08-01
RECRUITING
RADICAL-IO: thRee Cycles of immunotherApy Without raDical Therapy In mediCALly InOperable Stage I Non-small Cell Lung CancerNCT07808138 · collaborator · 2026-11-01
NOT_YET_RECRUITING

Drugs studied in this sponsor's trials

25 mapped RxNorm concepts

These drug records are connected through ClinicalTrials.gov studies listing Leiden University Medical Center as a sponsor, collaborator or responsible party. Each count is the number of distinct trials containing the mapped drug intervention. This does not establish that the organization manufactures, owns, sells or developed the drug.

Most studied mapped drug conceptsDistinct linked trials per RxNorm concept; one trial may study several drugs.
placebo4
methotrexate3
liraglutide2
abatacept1
abiraterone acetate1
adalimumab1
alectinib1
aspirin1
placebo RxCUI 8375 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 4 trials methotrexate RxCUI 6851 · Lead sponsor in 2 linked trial(s) · 1 currently recruiting 3 trials liraglutide RxCUI 475968 · Lead sponsor in 2 linked trial(s) · 0 currently recruiting 2 trials abatacept RxCUI 614391 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial abiraterone acetate RxCUI 1100071 · Lead sponsor in 1 linked trial(s) · 1 currently recruiting 1 trial adalimumab RxCUI 327361 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial alectinib RxCUI 1727455 · Lead sponsor in 0 linked trial(s) · 1 currently recruiting 1 trial aspirin RxCUI 1191 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial cyclophosphamide RxCUI 3002 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial dexamethasone RxCUI 3264 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial dolutegravir RxCUI 1433868 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 1 trial doxycycline RxCUI 3640 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 1 trial enzalutamide RxCUI 1307298 · Lead sponsor in 1 linked trial(s) · 1 currently recruiting 1 trial fluorouracil RxCUI 4492 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial heparin RxCUI 5224 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 1 trial maraviroc RxCUI 620216 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 1 trial mitoxantrone hydrochloride RxCUI 203129 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial placebo Oral Tablet RxCUI 375221 · Lead sponsor in 0 linked trial(s) · 1 currently recruiting 1 trial praziquantel RxCUI 8628 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 1 trial prednisolone RxCUI 8638 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 1 trial prednisone RxCUI 8640 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial rivastigmine RxCUI 183379 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 1 trial rocuronium RxCUI 68139 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial talazoparib RxCUI 2099704 · Lead sponsor in 0 linked trial(s) · 1 currently recruiting 1 trial

Sponsor roles

lead sponsor51
collaborator40
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.